Neurocrine Biosciences (NBIX) EV to Revenue (2009 - 2026)
Neurocrine Biosciences (NBIX) EV to Revenue (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to Revenue |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 2.01 |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | 3.01 |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | 91,682.36 |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | 6.83 |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | 18.48 |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | 1.16 |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | 5.01 |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | 2.36 |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | 3.02 |
| 10 | Vireo Growth | 10.64 Bn | 10.52 Bn | 59.30 Mn | 30.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 8, 2026 | 5.35 |
| Jul 7, 2026 | 5.33 |
| Jul 6, 2026 | 5.22 |
| Jul 2, 2026 | 5.22 |
| Jul 1, 2026 | 5.01 |
| Jun 30, 2026 | 5.04 |
| Jun 29, 2026 | 5.08 |
| Jun 26, 2026 | 5.03 |
| Jun 25, 2026 | 4.89 |
| Jun 24, 2026 | 4.96 |
| Jun 23, 2026 | 4.81 |
| Jun 22, 2026 | 4.81 |
| Jun 18, 2026 | 4.70 |
| Jun 17, 2026 | 4.73 |
| Jun 16, 2026 | 4.64 |
| Jun 15, 2026 | 4.74 |
| Jun 12, 2026 | 4.75 |
| Jun 11, 2026 | 4.85 |
| Jun 10, 2026 | 4.79 |
| Jun 9, 2026 | 4.93 |